Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Sano T, Amano K, Ide T, Yokoyama K, Noguchi K, Nakamura H, Isoda H, Ohno M, Shirachi M, Morita Y, Yano Y, Sumie S, Kawaguchi T, Kuwahara R, Arinaga-Hino T, Takahashi H, Shakado S, Hirai F, Kawaguchi T. Sano T, et al. Among authors: takahashi h. Hepatol Res. 2023 Jan;53(1):26-34. doi: 10.1111/hepr.13837. Epub 2022 Sep 20. Hepatol Res. 2023. PMID: 36066400
Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease.
Oza N, Takahashi H, Eguchi Y, Kitajima Y, Kuwashiro T, Ishibashi E, Nakashita S, Iwane S, Kawaguchi Y, Mizuta T, Ozaki I, Ono N, Eguchi T, Fujimoto K, Anzai K. Oza N, et al. Among authors: takahashi h. Hepatol Res. 2014 Jul;44(7):812-7. doi: 10.1111/hepr.12176. Epub 2013 Jun 25. Hepatol Res. 2014. PMID: 23721476
Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.
Tanaka K, Hyogo H, Ono M, Takahashi H, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y; Japan Study Group of Non-alcoholic Fatty Liver Disease (JSG-NAFLD). Tanaka K, et al. Among authors: takahashi h. Hepatol Res. 2014 Nov;44(12):1196-207. doi: 10.1111/hepr.12293. Epub 2014 Feb 17. Hepatol Res. 2014. PMID: 24372862
Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J).
Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M, Araki N, Tanaka K, Yamaguchi M, Matsuda Y, Ide Y, Otsuka T, Ozaki I, Ono N, Eguchi T, Anzai K; Japan Study Group for NAFLD (JSG-NAFLD). Eguchi Y, et al. Among authors: takahashi h. Hepatol Res. 2015 Mar;45(3):269-78. doi: 10.1111/hepr.12351. Epub 2014 May 28. Hepatol Res. 2015. PMID: 24796231
Prevalence of pruritus in patients with chronic liver disease: A multicenter study.
Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Oeda S, et al. Among authors: takahashi h. Hepatol Res. 2018 Feb;48(3):E252-E262. doi: 10.1111/hepr.12978. Epub 2017 Oct 10. Hepatol Res. 2018. PMID: 28877392
14,168 results
You have reached the last available page of results. Please see the User Guide for more information.